Detalhe da pesquisa
1.
A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells.
Nucleic Acids Res;
51(9): 4660-4673, 2023 05 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37070192
2.
DNA Damage: From Threat to Treatment.
Cells;
9(7)2020 07 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32664329
3.
A versatile reporter system for multiplexed screening of effective epigenome editors.
Nat Protoc;
15(10): 3410-3440, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32887975